BR9607964A - Processo de preparação de um medicamento para tratar doença inflamatória do intestino - Google Patents
Processo de preparação de um medicamento para tratar doença inflamatória do intestinoInfo
- Publication number
- BR9607964A BR9607964A BR9607964-9A BR9607964A BR9607964A BR 9607964 A BR9607964 A BR 9607964A BR 9607964 A BR9607964 A BR 9607964A BR 9607964 A BR9607964 A BR 9607964A
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- drug
- inflammatory bowel
- bowel disease
- treat inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"PROCESSO DE PREPARAçãO DE UM MEDICAMENTO, FORMA DE DOSAGEM UNITáRIA, MICROPARTìCULAS ENTERCIAMENTE REVESTIDAS, E, COMPOSIçãO FARMACêUTICA". é fornecido um processo para tratar doença inflamatória de bexiga por administração topicamente ao cólon de uma quantidade de azatioprina ou de um sal farmaceuticamente aceitável da mesma, de preferência por meio de formulações adaptadas para administração oral ou retal de liberação retardada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/413,505 US5691343A (en) | 1995-03-30 | 1995-03-30 | Use of topical azathioprine to treat inflammatory bowel disorders |
PCT/US1996/003383 WO1996030021A1 (en) | 1995-03-30 | 1996-03-12 | Azathioprine compositions for colonic administration |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607964A true BR9607964A (pt) | 1999-11-30 |
Family
ID=23637470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607964-9A BR9607964A (pt) | 1995-03-30 | 1996-03-12 | Processo de preparação de um medicamento para tratar doença inflamatória do intestino |
Country Status (18)
Country | Link |
---|---|
US (2) | US5691343A (pt) |
EP (1) | EP0817634A1 (pt) |
JP (1) | JPH11502842A (pt) |
KR (1) | KR19980703423A (pt) |
AP (1) | AP727A (pt) |
AU (1) | AU707168B2 (pt) |
BR (1) | BR9607964A (pt) |
CA (1) | CA2216728A1 (pt) |
CZ (1) | CZ290428B6 (pt) |
EA (1) | EA199700282A1 (pt) |
HU (1) | HUP9801241A3 (pt) |
IS (1) | IS4561A (pt) |
NO (2) | NO311491B1 (pt) |
NZ (1) | NZ306062A (pt) |
OA (1) | OA10517A (pt) |
PL (1) | PL322526A1 (pt) |
TR (1) | TR199701079T1 (pt) |
WO (1) | WO1996030021A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028190A (en) | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
US6166024A (en) | 1995-03-30 | 2000-12-26 | Mayo Foundation For Medical Education And Research | Use of topical azathioprine and thioguanine to treat colorectal adenomas |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
DE69824748T2 (de) * | 1997-09-26 | 2005-08-25 | Celltech Pharma Europe Ltd. | Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen |
US6355623B2 (en) | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
US7323471B1 (en) | 1999-08-13 | 2008-01-29 | Dor Biopharma, Inc. | Topical azathioprine for the treatment of oral autoimmune diseases |
US6689788B1 (en) | 2000-08-25 | 2004-02-10 | University Of Florida | Method and composition for treatment of inflammatory bowel disease |
US6946258B2 (en) | 2002-03-04 | 2005-09-20 | Biologix Diagnostics, Llc | Rapid, immunochemical process for measuring thiopurine methyltransferase |
IL152127A0 (en) * | 2002-10-06 | 2003-05-29 | Bio Balance Corp | Probiotic compositions for the treatment of inflammatory bowel disease |
US7067460B2 (en) | 2002-11-14 | 2006-06-27 | Baker Hughes Incorporated | Organofunctional compounds for shale stabilization of the aqueous dispersed phase of non-aqueous based invert emulsion drilling system fluids |
AU2005232582B2 (en) * | 2004-04-01 | 2009-05-21 | Teva Pharmaceutical Industries Ltd. | Imroved formulations of 6-mercaptopurine |
US8188067B2 (en) | 2004-04-01 | 2012-05-29 | Teva Pharmaceutical Industries Ltd. | Formulations of 6-mercaptopurine |
US7923014B2 (en) * | 2007-02-12 | 2011-04-12 | The Board Of Regents Of The University Of Texas System | Expression and purification of HIP/PAP and uses therefor |
US7919251B2 (en) | 2007-10-12 | 2011-04-05 | Guy's And St. Thomas' Nhs Foundation Trust | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy |
US20090263482A1 (en) * | 2008-04-18 | 2009-10-22 | Vered Rosenberger | Treatment of inflammatory bowel disease with 6-mercaptopurine |
CN108289894A (zh) * | 2015-09-29 | 2018-07-17 | 前药扩展私人有限公司 | 新型制剂和治疗方法 |
US20170105996A1 (en) | 2015-10-16 | 2017-04-20 | Teva Pharmaceutical Industries, Ltd. | Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3056785A (en) * | 1960-03-21 | 1962-10-02 | Burroughs Weilcome & Co U S A | Purine derivatives |
US4350690A (en) * | 1980-10-27 | 1982-09-21 | Cressington Investments Ltd. | Steroid composition |
US4627851A (en) * | 1984-10-26 | 1986-12-09 | Alza Corporation | Colonic-therapeutic delivery system |
JPS6272618A (ja) * | 1985-09-27 | 1987-04-03 | Kanji Takada | アザチオプリン製剤 |
GB8812490D0 (en) * | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
DK66493D0 (da) * | 1993-06-08 | 1993-06-08 | Ferring A S | Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling |
-
1995
- 1995-03-30 US US08/413,505 patent/US5691343A/en not_active Expired - Fee Related
-
1996
- 1996-03-12 TR TR97/01079T patent/TR199701079T1/xx unknown
- 1996-03-12 HU HU9801241A patent/HUP9801241A3/hu unknown
- 1996-03-12 EA EA199700282A patent/EA199700282A1/ru unknown
- 1996-03-12 JP JP8529440A patent/JPH11502842A/ja active Pending
- 1996-03-12 CZ CZ19973092A patent/CZ290428B6/cs not_active IP Right Cessation
- 1996-03-12 EP EP96911292A patent/EP0817634A1/en not_active Withdrawn
- 1996-03-12 AP APAP/P/1997/001098A patent/AP727A/en active
- 1996-03-12 AU AU54218/96A patent/AU707168B2/en not_active Ceased
- 1996-03-12 KR KR1019970706827A patent/KR19980703423A/ko not_active Application Discontinuation
- 1996-03-12 WO PCT/US1996/003383 patent/WO1996030021A1/en not_active Application Discontinuation
- 1996-03-12 PL PL96322526A patent/PL322526A1/xx unknown
- 1996-03-12 NZ NZ306062A patent/NZ306062A/xx unknown
- 1996-03-12 BR BR9607964-9A patent/BR9607964A/pt not_active Application Discontinuation
- 1996-03-12 CA CA002216728A patent/CA2216728A1/en not_active Abandoned
-
1997
- 1997-08-01 US US08/905,490 patent/US5905081A/en not_active Expired - Fee Related
- 1997-09-18 IS IS4561A patent/IS4561A/is unknown
- 1997-09-25 NO NO19974440A patent/NO311491B1/no not_active IP Right Cessation
- 1997-09-30 OA OA70090A patent/OA10517A/en unknown
-
2001
- 2001-06-13 NO NO20012930A patent/NO20012930D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU707168B2 (en) | 1999-07-01 |
HUP9801241A2 (hu) | 1998-09-28 |
NO974440L (no) | 1997-09-25 |
NZ306062A (en) | 1998-10-28 |
NO974440D0 (no) | 1997-09-25 |
AP727A (en) | 1999-01-29 |
AU5421896A (en) | 1996-10-16 |
NO20012930D0 (no) | 2001-06-13 |
CA2216728A1 (en) | 1996-10-03 |
JPH11502842A (ja) | 1999-03-09 |
AP9701098A0 (en) | 1997-10-31 |
WO1996030021A1 (en) | 1996-10-03 |
PL322526A1 (en) | 1998-02-02 |
HUP9801241A3 (en) | 2000-06-28 |
CZ290428B6 (cs) | 2002-07-17 |
US5691343A (en) | 1997-11-25 |
MX9707391A (es) | 1997-11-29 |
OA10517A (en) | 2002-04-24 |
KR19980703423A (ko) | 1998-11-05 |
NO311491B1 (no) | 2001-12-03 |
TR199701079T1 (xx) | 1998-01-21 |
NO20012930L (no) | 1997-09-25 |
IS4561A (is) | 1997-09-18 |
EP0817634A1 (en) | 1998-01-14 |
CZ309297A3 (cs) | 1998-03-18 |
EA199700282A1 (ru) | 1998-04-30 |
US5905081A (en) | 1999-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9607964A (pt) | Processo de preparação de um medicamento para tratar doença inflamatória do intestino | |
BR9408378A (pt) | Composto sal farmaceuticamente aceitável composição farmacêutica e processos para o tratamento de um paciente que sofreu um derrame e que sofre de uma condição de perda progressiva de função de sistema nervoso central e para melhorar os efeitos colaterais causados em um paciente por tratamento antineoplástico de doença que produz danos oxidativos | |
BR122012014331B8 (pt) | formulações farmacêuticas | |
CY1111088T1 (el) | Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση | |
BR9814378A (pt) | Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase | |
BR9908030A (pt) | Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado | |
IL124977A0 (en) | Oral administration of effective amounts of forms of hyaluronic acid | |
WO2000050027A1 (en) | Gabapentin derivative for preventing and treating visceral pain | |
DE69331409D1 (de) | Oral 1alpha-hydroxyprevitamin d | |
KR930007441A (ko) | 의약품 | |
RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
FR2798065B1 (fr) | Utilisation de la nicotine ou de ses derives dans un medicament pour le traitement des maladies neurologiques, notamment la maladie de parkinson | |
PT1992333E (pt) | Combinações de flurbiprofeno e relaxantes musculares | |
KR930009605A (ko) | 소염 또는 진통제 | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
AR035946A1 (es) | Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos | |
BR9704114A (pt) | Processo de tratamento de doenças vasculares progressivas crÈnicas | |
BR9809396A (pt) | Método de tratamento de doenças de cicatrização vascular progressivas | |
KR970005283A (ko) | 심근경색발생 후의 환자를 처치하기 위한 서트랄린의 용도 | |
JP5386478B2 (ja) | パーキンソン病に伴う運動不全の治療のための4−シクロプロピルメトキシ−n−(3,5−ジクロロ−1−オキシドピリジン−4−イル)−5−(メトキシ)ピリジン−2−カルボキサミドの使用 | |
KR890014110A (ko) | 의약제 | |
EP0901376A1 (en) | Malatonin in combination with analgesics | |
BR0009327A (pt) | Composição farmacêutica para a terapia de sintomas do trato urinário inferior | |
US4575506A (en) | Method of treatment for inhibiting the tolerance onset while treating painful syndromes with central analgesics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal |